Genenta Science S.p.A. Unsponsored ADR

SAEN Industrials Conglomerates

0.61 0.04 −6.15%
Market cap
$31.3M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 40.64%

Capital & Financial Ratios $m

Size
Market Cap 31.33
Revenue ttm —
Net income ttm (25.72)
Free cash flow ttm (23.02)
Net debt Q (23.25)
Valuation
P/E —
Forward P/E —
Price / sales 0.00
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.00
Financial health
Current ratio Q 14.16 (at or above 1.5: strong)
Debt / equity Q 0.35 (at or below 0.5: strong)
Interest coverage Q —
Growth
Revenue growth Q —
Operating income growth Q —
EPS, this year +10.95%
EPS, next year A −15.22% (below 0%: weak)
Revenue, next year A —
EPS, past 5 yrs —
EPS, next 5 yrs A +28.35% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/FCF against its own 10 years 77.01%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2022 2023 2024 2025
Cash 31 20 14 32
Receivables — — — —
Inventory — — — —
Other — — — —
33 23 16 34
2022 2023 2024 2025
Payables 1 1 1 2
ST’ Debt — — — —
Other 0 0 0 0
2 2 2 2

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 7.38% (9.01%)

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (0.37)
’24 — — — — (0.53)
’23 — — — — (0.69)
’22 — — — — (0.50)
’21 — — — — (0.43)
’20 — — — — (0.44)
Fiscal quarters ending in the months shown.

Revenue $m

Year
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (8)
’24 — — — — (7)
’23 — — — — (12)
’22 — — — — (8)
’21 — — — — (8)
’20 — — — — (7)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — (6) — (8) (8)
’24 — (2) — (7) (7)
’23 — (8) — (12) (12)
’22 — (3) — (8) (8)
’21 — (6) — (8) (8)
’20 — — — (7) (7)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — — — — — — 42 42 42 0.0%
Gross margin, % — — — — 0.00 0.00 0.00 — — — 0.0 pt
EBT — — — (5) (6) (7) (9) (13) (10) (7) +6.2%
EBT margin, % — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0 pt
Net income — 0 — (5) (6) (7) (9) (13) (10) (7) n/m
Per share, $
Per share, $ Revenue — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 n/m
Earnings — — — (0.28) (0.44) (0.43) (0.50) (0.69) (0.53) (0.37) +4.8%
Cash flow — — — (0.15) (0.47) (0.55) (0.43) (0.67) (0.37) (0.39) +17.0%
Capex — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 n/m
Free cash flow — — — (0.15) (0.48) (0.55) (0.43) (0.67) (0.37) (0.39) +17.0%
Book value — — — 1.17 1.19 3.05 1.80 1.21 0.74 1.25 +1.2%
Shares, m — — — 18 15 15 18 18 18 20 +1.4%
Valuation, ×
Valuation, × P/E — — — — — — — — — — —
P/S — — — — — — — — — — —
P/B — — — — — — — — — — —
EV/Sales — — — — — — — — — — —
EV/FCF — — — — — — — — — — —
Cash, $m
Cash, $m Operating cash flow — — — (3) (7) (8) (8) (12) (7) (8) +18.6%
Capex — — — — 0 0 0 0 0 0 (18.4%)
Free cash flow — — — (3) (7) (8) (8) (12) (7) (8) +18.7%
Balance, $m
Balance, $m Working capital — — — 20 16 45 31 21 13 32 +7.6%
Net debt — — — (23) (18) (44) (31) (20) (14) (23) +0.5%
Shareholders’ equity — — — 21 17 46 33 22 14 25 +2.6%
Returns, %
Returns, % ROA — — — (42.95) (29.06) (19.43) (21.63) (42.43) (47.95) (28.35) +14.6 pt
ROIC — — — 0.00 0.00 (219.27) (513.85) (442.67) 0.00 (318.86) (318.9) pt
ROE — — — (25.93) (33.21) (20.67) (22.68) (45.90) (54.13) (38.65) (12.7) pt
People
People Employees — — — — 4 7 9 14 13 9 +17.6%
Revenue/emp, $m — — — — 0.00 0.00 0.00 0.00 0.00 0.00 n/m
Negative figures in brackets.
estimates

All 10 years →

Genenta Science S.p.A. Unsponsored ADR vs peers in Conglomerates (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
BOOM DMC Global $144.9M — (loss-making) 30.2× +14.05% (above 0%: growing) n/m +2.19% (above 0%: growing) 26.87% 8.39% Compare
TUSK Mammoth Energy Services, Inc. $143.4M 10.1× 5.4× +96.70% (above 0%: growing) n/m −152.84% (below 0%: shrinking) 46.65% (1.97%) Compare
AIRT Air T, Inc. $75.4M 1.2× — (loss-making) +62.92% (above 0%: growing) n/m −1,721.49% (below 0%: shrinking) 63.67% (11.11%) Compare
AIAI AIAI Holdings Corporation $71.3M — — — n/m — 8.49% (78.02%) Compare
SAEN Genenta Science S.p.A. Unsponsored ADR $31.3M — — — — +35.94% (above 0%: growing) 0.00% —
HHS Harte Hanks, Inc. $29.9M — (loss-making) — −1.67% (below 0%: shrinking) n/m +59.98% (above 0%: growing) 14.75% (11.82%) Compare
GPUS Hyperscale Data, Inc. $28.1M — (loss-making) 9.9× +34.75% (above 0%: growing) n/m −696.15% (below 0%: shrinking) 25.24% (66.34%) Compare
LGPS LogProstyle Inc. $14.1M — — — — −72.63% (below 0%: shrinking) — — Compare
PLAG PLANET GREEN HOLDINGS CORP. $5.0M — (loss-making) — −12.88% (below 0%: shrinking) n/m −200.71% (below 0%: shrinking) (89.00%) (146.86%) Compare
Median of peers $50.6M — 9.9× +24.40% — −152.84% 25.24% (11.82%)

All 29 Conglomerates stocks →

Genenta Science S.p.A. Unsponsored ADR (SAEN) Latest News

23 Apr

Impact 4 · · GlobeNewswire

19 Dec

Impact 3 · · GlobeNewswire

24 Nov

Impact 4 · · GlobeNewswireMT NewswiresClinical Trials ArenaMT Newswires

26 Oct

Impact 3 · · GlobeNewswireMT NewswiresMT NewswiresMT NewswiresMT NewswiresMT NewswiresMT NewswiresMT Newswires

14 Oct

Impact 3 · · Simply Wall St.

8 Jul

17 Feb

Impact 3 · · Simply Wall St.

13 Feb

stockrow.com/SAEN · For information only; not investment advice. · © 2026 stockrow.com